C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
167/179, 260/537
C07C 39/23 (2006.01) C07C 35/36 (2006.01) C07C 45/44 (2006.01) C07C 45/46 (2006.01) C07C 47/548 (2006.01) C07C 47/57 (2006.01) C07C 47/575 (2006.01) C07C 49/683 (2006.01) C07C 49/697 (2006.01) C07C 49/747 (2006.01) C07C 49/757 (2006.01) C07C 49/792 (2006.01) C07C 49/798 (2006.01) C07C 49/813 (2006.01) C07C 49/835 (2006.01) C07C 49/84 (2006.01) C07C 63/66 (2006.01) C07C 65/19 (2006.01) C07C 65/38 (2006.01) C07C 247/24 (2006.01)
Patent
CA 1317973
ABSTRACT OF THE DISCLOSURE: Disclosed are novel tetralin derivative of the formula (I): Image (I) where R1 is hydrogen, C1-C4-alkyl, C1-C4-alkoxy or halogen, R2 is hydrogen, C1-C6-alkyl or C3-C6-cycloalkyl, X is -CH2-CO-, -CH2-CHOH, -CH2-C(R4)OH-, -CH2-C(OCOR4)H-, -CH2-C(R4)(OCHOR5)-, -CHOH-CHOH-, -CH=CH-, -CH(OCOR4) -CH(OCOR4)-, -CH2-CH(OR4)- (where R4 and R5 are each C1-C4- alkyl) and R3 is nitrile, C2-C10-ketal or -CH(R7)(R8)- or -CO-R9, where R7 is hydrogen or C1-C3-alkyl, R8 is hydrogen, C1-C3-alkyl or -OR10 or -NR11R12 (where R10, R11 and R12 are each hydrogen, C1-C4-alkyl, C2-C20-alkanoyl or unsubstituted or substituted benzoyl) and R9 is hydrogen, halogen, C1-C4- alkyl, azido, or -OR13 (where R13 is hydrogen or C1-C8-alkyl or is C2-C6 alkyl which is substituted by one or more hydroxyl groups or a C1 -C4 - alkoxy group, or is aryl or aralkyl) and, where relevant, its physiologically tolerated salts. These derivatives are useful in the therapy of dermatological dis- orders and the prophylactic and therapeutic treatment of precanceroses and tumors.
491248
Frickel Fritz-Frieder
Nuerrenbach Axel
Wuest Hans-Heiner
Basf Aktiengesellschaft
Robic
LandOfFree
Tetralin derivatives, their preparation and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetralin derivatives, their preparation and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetralin derivatives, their preparation and their use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1220704